Skip to main content

Life Sciences Funding Opportunities

Last updated: 05/23/19. For additional funding resources, please see available funding on the EVPRP website


Purdue Institute for Integrative Neuroscience

Funding Opportunity

Award Amount

Deadline

Advancing Basic Neurobiology Toward Translation Through Assay Development (R01)

Varies

June 5, 2019

Drug Discovery For Nervous System Disorders (R01)

Varies

June 5, 2019

Autism Science Foundation Research Accelerator Grant

Varies

June 14, 2019

NIH Exploiting Genome or Epigenome Editing to Functionally Validate Genes or Variants Involved in Substance Use Disorders (R21/R33)  

Varies

June 24, 2019

NSF Next Generation Networks for Neuroscience

Varies

Preliminary Proposal June 14, 2019

DOD-CDMRP Epilepsy Research Program (ERP)  

Varies

Pre-application June 26, 2019

DOD-CDMRP FY19 Parkinson’s Research Program (PRP) Investigator-Initiated Research Award

Varies

LOI July 9, 2019

DOD-CDMRP FY19 Parkinson's Research Program (PRP) Early Investigator Research Award

Varies

LOI July 9, 2019

NSF Science of Learning

Varies

July 10, 2019

NSF Cognitive Neuroscience (CogNeuro)  

Varies

August 13, 2019

NIH Centers Without Walls for Collaborative Research in the Epilepsies: Functional Evaluation of Human Genetic Variants (U54)

$1,500,000

August 27, 2019

NIH BRAIN Initiative: Secondary Analysis and Archiving of BRAIN Initiative Data (R01)  

Varies

September 6, 2019

Purdue Institute of Inflammation, Immunology and Infectious Disease

Funding Opportunity

Award Amount

Deadline

NIH Notice of Intent to Publish Funding Opportunity Announcements to Promoter Implementation Science (R01) and Dissemination and Implementation Studies (R18)

Varies

Calendar Year

Alfred P. Sloan Foundation

Varies

On-going

NIH-NIAID Omnibus Broad Agency Announcement

Varies

Varies

Immune Epitope and Analysis Resource Program

Varies

Varies

Trophoblast Differentiation and Function (R21 Clinical Trial Optional)

Varies

Varies

DOD-CDMRP Ovarian Cancer

Varies

Varies

ORAU Higher Education Research Experiences for Faculty at Oak Ridge National Laboratory

Varies

On-going

State Department launches U.S _Indian Higher Education Research Collaboration Initiative

Varies

On-going

DOD-CDMRP FY19 Lung Cancer Research Program (LCRP)

Varies

On-going

NIH Computational Models of Immunity (U01)

Varies

June 10, 2019

NIH Research Projects to Improve the Predictive Value of Animal Models in Recapitulating Human Immunity to Influenza Infection and Vaccination

Varies

June 10, 2019

NIH Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer

Varies

June 10, 2019
June 10, 2019

NIH Novel RNAs in Virology (including HIV) and Immune Regulation: Basic Science and Therapeutic Discovery (R21)

Varies

June 16, 2019

NIH Research Projects to Improve the Predictive Value of Animal Models in Recapitulating Human Immunity to Influenza Infection and Vaccination

Varies

June 18, 2019

NIH Emerging Infectious Diseases Research Centers (U01)

Varies

June 28, 2019

DOD Multidisciplinary Research Program of the University Research Initiative (MURI)

Varies

June 28, 2019 - White paper
October 16, 2019 - Application

NIH Geroscience Approaches to Alzheimer's Disease

Varies

July 2, 2019
July 2, 2019

NIH Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention

Varies

July 2, 2019
July 2, 2019

NIH Short-term Mentored Career Enhancement Awards in Mobile and Wireless Health Technology and Data Analytics: Cross-Training at the intersection of Behavioral and Social Sciences and STEM Disciplines (K18)

Varies

July 12, 2019

NIH Feasibility of Novel Diagnostics for TB in Endemic Countries (FEND for TB) (U01)

Varies

July 22, 2019

NIH U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (HIV/AIDS) (R01)

Varies

July 26, 2019

NIH U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (Infectious Diseases) (R01)

Varies

July 26, 2019

NIH Advancing Biomarker Discovery and Novel Point-of-Care Diagnostics for Active TB Disease Detection in HIV-1 Infected and Exposed Children (R01)

Varies

July 30, 2019

NIH Development of Sample Sparing Assays for Monitoring Immune Responses (U24)

Varies

July 30, 2019

MacArthur Foundation 100&Change

Varies

July 30, 2019

NIH Directors Transformative Research Awards (R01)

Varies

September 20, 2019

NIH Informatics Methodology and Secondary Analyses for Immunology Data in ImmPort (UH2)

Varies

October 1, 2019

HHS Office of Biomedical Advanced Research and Development Authority (BARDA) BAA

Varies

October 31, 2019

DOD-CDMRP BAA for Extramural Biomedical Research and Development

Varies

On-going through July 31, 2023

Purdue Institute for Drug Discovery

Funding Opportunity

Award Amount

Deadline

G. Harold and Leila Y. Mathers Foundation

Varies

On-going

DOD-CDMRP Peer Reviewed Medical Research Program  

Varies

Rolling

DOD-CDMRP Breast Cancer

Varies

Rolling

Antibacterial Resistance Leadership Group (ARLG) Collaboration

Varies

Rolling

Alpha-Synuclein Imaging Prize

2,000,000

Rolling

NIH Microbial-based Cancer Therapy -Bugs as Drugs (R01)

Varies

June 5, 2019

NIH Biology of Bladder Cancer  (R01)

Varies

June 5, 2019

NIH Biology of Bladder Cancer (R01)

Varies

June 5, 2019

Discovering Novel Targets: The Molecular Genetics of Drug Addiction and Related Co-Morbidities (R01)

Varies

June 5, 2019

Advancing Basic Neurobiology Toward Translation Through Assay Development (R01)

Varies

June 5, 2019

DOD-CDMRP Prostate Cancer Research Program (PCRP)  

Varies

Pre-application
June 6, 2019

NIH Research Projects to Improve the Predictive Value of Animal Models in Recapitulating Human Immunity to Influenza Infection and Vaccination  (R01)

Varies

June 10, 2019

NIH Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R01)

Varies

June 10, 2019

NIH Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R21)

$275,000

June 10, 2019

NIH Computational Models of Immunity (U01)

Varies

June 10, 2019

Lung Cancer Research Foundation Pilot Grant Program  

Varies

June 14, 2019

Drug Discovery For Nervous System Disorders (R01)

Varies

June 15, 2019

NIH Biology of Bladder Cancer  (R21)

$275,000

June 15, 2019

NIH Novel RNAs in Virology (including HIV) and Immune Regulation: Basic Science and Therapeutic Discovery (R21)

$275,000

June 16, 2019

NIH Biology of Bladder Cancer  (R21)

$275,000

June 16, 2019

NIH Research Projects to Improve the Predictive Value of Animal Models in Recapitulating Human Immunity to Influenza Infection and Vaccination  (R21)

$275,000

June 18, 2019

Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3)

Varies

June 20, 2019

Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01)

Varies

June 25, 2019

Damon Runyon-Rachleff Innovation Award

Varies

July 1, 2019

NIH Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer (R01)   

Varies

July 10, 2019

Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3)

Varies

August 9, 2019

NIH Director’s New Innovator Award Program (DP2)  

$1,500,000

August 26, 2019

Countermeasures Against Chemical Threats (CounterACT): Identification of Therapeutic Lead Compounds (U01 Clinical Trial Not Allowed)

$300,000

September 10, 2019

Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01 Clinical Trial Optional)

Varies

September 10, 2019

NIH Directors Transformative Research Awards (R01) 

Varies

September 20, 2019

Purdue University Institute for Plant Sciences

Funding Opportunity

Award Amount

Deadline

USDA-NIFA Agriculture and Food Research Initiative - Sustainable Agricultural Systems

$5,000,000- $10,000,000

June 9

DOI Noxious and Invasive Plant Management Program

$1,500 - $200,000

August 31

Purdue Center for Cancer Research

Funding Opportunity

NIH Funding Opportunities

NIH Dissemination and Implementation Research in Health
R01 Deadline: June 5
R03 Deadline: June 16
R21 Deadline: June 16

NIH Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21)

NIH Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01)

NIH Sustained Support for Informatics Technologies for Cancer Research and Management (U24)

NIH Advanced Development of Informatics Technologies for Cancer Research and Management (U24)

NIH Exploratory Grants in Cancer Epidemiology (R21)

NIH Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention
R01 Deadline: July 2
R21 Deadline: July 2

NIH Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer (R01)

NIH U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (HIV/AIDS) (R01)

NIH Director’s New Innovator Award Program (DP2)

NIH HLA and KIR Region Genomics in Immune-Mediated
U01 Deadline: September 4
U19 Deadline: September 4

NIH Directors Pioneer Award Program (DP1)

NIH Directors Early Independence Awards (DP5)

NIH Directors Transformative Research Awards (R01)

NIH Microbial-based Cancer Therapy -Bugs as Drugs (R01)

NIH Biology of Bladder Cancer This FOA encourages applications investigating the biology and underlying mechanisms of bladder cancer. While recent progress has been made in the molecular profiling of bladder cancers and identification of mutated genes, relatively little is known regarding the molecular mechanisms driving initiation, progression, and malignancy of bladder cancer. Furthermore, our understanding of biological processes of the normal bladder at the molecular, cell and organ levels is limited. Fundamental knowledge of how molecular and cellular functions of the bladder are altered in cancer will aid our understanding of bladder cancer biology and interventions. Applications that involve multidisciplinary teams and use clinical specimens or investigate both normal and cancer processes are encouraged.

  • R01 Deadline: June 5
  • R21 Deadline: June 16

NIH Mechanisms Underlying the Contribution of Sleep Disturbances to Pain The purpose of this FOA is to encourage mechanistic research to investigate the impact of sleep disturbances on pain. The mechanisms and processes underlying the contribution of sleep and sleep disturbances to pain perception and the development and maintenance of chronic pain may be very broad. This FOA encourages interdisciplinary research collaborations by experts from multiple fields—neuroscientists, psychologists, endocrinologists, immunologists, geneticists, pharmacologists, chemists, physicists, behavioral scientists, clinicians, caregivers, and others in relevant fields of inquiry.

  • R01 Deadline: June 5
  • R21 Deadline: June 16

NIH Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer The purpose of this FOA is to support research which can elucidate mechanism(s) of action by which gut microbes inhibit or enhance anti-tumor immune responses. Thus, research projects should be focused on delineating how specific microbes or their metabolites target host immune responses to prevent colitis-associated or sporadic tumor formation.

  • R01 Deadline: June 10
  • R21 Deadline: June 10

NIH Tobacco Regulatory Science (R01)

NIH Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01)

NIH Notice of Intent to Publish a FOA for Diversity Program Consortium Dissemination and Translation Awards (U01)

NIH Administrative Supplements to Existing NIH Grants and Cooperative Agreements. The National Institutes of Health (NIH) hereby notify Program Directors/Principal Investigators (PD(s)/PI(s)) holding specific types of NIH research grants listed in the full Funding Opportunity Announcement (FOA) that funds may be available for administrative supplements to meet increased costs that are within the scope of the approved award, but were unforeseen when the new or renewal application or grant progress report for non-competing continuation support was submitted.

Other Cancer Funding Opportunities

Funding Opportunity

Deadline

DOD-CDMRP Prostate Cancer Research Program (PCRP) The PCRP seeks to promote highly innovative, groundbreaking research; high-impact research with near-term clinical relevance; the next generation of prostate cancer investigators through mentored research; and resources that will facilitate translational research. Mechanisms include: Idea Development Award; Early Investigator Research Award; and Physician Research Award. Deadlines: June 6 – Pre-application; Application deadline depends on mechanism

June 6 – Pre-application

Damon Runyon-Rachleff Innovation Award The Damon Runyon-Rachleff Innovation Award provides support for the next generation of exceptionally creative thinkers with "high-risk/high-reward" ideas that have the potential to significantly impact our understanding of and/or approaches to the prevention, diagnosis and treatment of cancer. This award is specifically designed to provide funding for extraordinary early career researchers who have an innovative, new idea but lack sufficient preliminary data to obtain traditional funding. The research supported by the award must be novel, exceptionally creative and, if successful, have the strong potential for high impact in the cancer field.

July 1

NSF Biophotonics

On-going through August 15, 2019

NSF Centers for Chemical Innovation (CCI) The CCI Program supports research centers focused on major, long-term fundamental chemical research challenges. CCIs that address these challenges will produce transformative research, lead to innovation, and attract broad scientific and public interest. CCIs are agile structures that can respond rapidly to emerging opportunities through enhanced collaborations. CCIs integrate research, innovation, education, broadening participation, and informal science communication.

Deadlines: August 13 – Phase I preliminary proposal; February 19 – Phase I full proposal; October 16 – Phase II full proposal

NSF Division of Chemistry: Disciplinary Research Programs (CHE-DRP) This solicitation applies to nine CHE Disciplinary Chemistry Research Programs: Chemical Catalysis (CAT); Chemical Measurement and Imaging (CMI); Chemical Structure, Dynamics and Mechanisms-A (CSDM-A); Chemical Structure Dynamics and Mechanisms-B (CSDM-B); Chemical Synthesis (SYN); Chemical Theory, Models and Computational Methods (CTMC); Chemistry of Life Processes (CLP); Environmental Chemical Sciences (ECS); and Macromolecular, Supramolecular and Nanochemistry (MSN). All proposals submitted to these nine CHE Disciplinary Research Programs (other than the following exceptions) must be submitted through this solicitation.

Submission window: September 1 to September 30

NSF Division of Molecular and Cellular Biosciences: Investigator-initiated research projects (MCB)

On-going

DOE-JGI CSP New Investigator

On-going

NSF Big Ideas updates

Varies

DOD-CDMRP Peer Reviewed Medical Research Program The program includes several mechanisms including: Discovery Award; Focused Program Award; Investigator-Initiated Research Award, and Technology/Therapeutic Development Award.

Varies

DOD-CDMRP FY19 Peer Reviewed Cancer Research Program (PRCRP)

Varies

DOD-CDMRP FY19 Lung Cancer Research Program (LCRP)

Varies

DOD-CDMRP Breast Cancer

Varies

DOD-CDMRP Ovarian Cancer

Varies

The AACR is currently accepting applications for the following opportunities:
Grants for mentored researchers in the areas of lung, ovarian, pediatric, and breast cancer research, lymphoma, myeloma, and all areas of clinical and translational cancer research
A grant for tenure-eligible junior faculty focused on any area of cancer research
A grant for established investigators in the field of neuroendocrine tumor research
Learn More
Apply Now

Varies

Limited Submissions
Purdue Internal Deadlines for Proposals
Numerous new opportunities, follow link for details

Varies

The Fiscal Year 2019 (FY19) Defense Appropriation Act provides funding for the peer reviewed programs managed by the Department of Defense (DOD) office of Congressionally Directed Medical Research Programs (CDMRP). This e-mail is to notify the research community of recently released pre-announcements (http://cdmrp.army.mil/pubs/press/press) to allow investigators time to plan and develop ideas for submission to the anticipated FY19 funding opportunities.

FY19 funding opportunities are anticipated to be released in January 2019 for the following programs:

Breast Cancer Research Program
Ovarian Cancer Research Program

Descriptions of each of the anticipated funding opportunities, eligibility, key mechanism elements, and funding can be found in the respective Program pre-announcement. FY19 pre-announcements can be found in the CDMRP home page features at http://cdmrp.army.mil.

Varies

Peer Reviewed Medical Research Program
Clinical Trial Award
Discovery Award
Focused Program Award
Investigator-Initiated Research Award
Technology/Therapeutic Development Award

Detailed descriptions of the funding opportunity, evaluation criteria, and submission requirements can be found in the Program Announcements. The Program Announcements are available electronically for downloading from the Grants.gov website (http://www.grants.gov), the CDMRP website (https://cdmrp.army.mil/funding/default) and the electronic Biomedical Research Application Portal (eBRAP) (https://eBRAP.org).

All CDMRP funding opportunities, both recently and previously released, are available on the CDMRP website (https://cdmrp.army.mil).

Subsequent notifications will be sent when additional funding opportunities are released. A listing of all open CDMRP funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

Submission is a two-step process requiring both pre-application submission and full application submission. All pre-applications must be submitted through eBRAP (https://eBRAP.org/). Full applications from extramural organizations (non-DoD organizations) must be submitted through Grants.gov (http://www.grants.gov/). Intramural DoD organizations may submit full applications to either eBRAP or Grants.gov. Refer to the General Application Instructions, Section II.A. for registration and submission requirements for eBRAP and Grants.gov. For detailed information on the submission process, refer to Section II.D. of the Program Announcement/Funding Opportunity.

Varies

Defense Health Program
https://cdmrp.army.mil/pubs/press/2019/19kcrppreann
Department of Defense Kidney Cancer Research Program
Funding Opportunities for Fiscal Year 2019 (FY19)

Varies

Notifying the research community of recently released pre-announcements for the Lung Cancer and Tick-Borne Disease Research Programs managed by the Department of Defense office of Congressionally Directed Medical Research Programs (CDMRP) https://cdmrp.army.mil/pubs/press/press to allow investigators time to plan and develop ideas for submission to the anticipated FY19 funding opportunities.

FY19 funding opportunities are anticipated for the following programs:

Lung Cancer Research Program (LCRP)

  • Concept Award
  • Career Development Award
  • Idea Development Award
  • Investigator-Initiated Translational Research Award
  • Translational Research Partnership Award

Tick-Borne Disease Research Program (TBDRP)

  • Investigator-Initiated Research Award
  • Idea Award
  • Career Development Award

Descriptions of each of the anticipated funding opportunities, eligibility, key mechanism elements, and funding can be found in the Program pre-announcement. FY19 pre-announcements can be found in the CDMRP home page features at https://cdmrp.army.mil.
Subsequent notifications will be sent when the program announcements/funding opportunities are released.
Please do not respond directly to this message. To be added or removed from this email list please use the “Subscribe/unsubscribe” to program specific news and updates at https://ebrap.org.

Varies

    Purdue University, 610 Purdue Mall, West Lafayette, IN 47907, (765) 494-4600

    © 2019 Purdue University | An equal access/equal opportunity university | Copyright Complaints

    Trouble with this page? Disability-related accessibility issue? Please contact us at vprweb@purdue.edu.